[HTML][HTML] The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum

R Loveikyte, AR Bourgonje, H van Goor, G Dijkstra… - Redox Biology, 2023 - Elsevier
One in five patients with Inflammatory Bowel Disease (IBD) suffers from anemia, most
frequently caused by iron deficiency. Anemia and iron deficiency are associated with worse …

Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations

R He, S Zhao, M Cui, Y Chen, J Ma, J Li… - Frontiers in …, 2023 - frontiersin.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disease typically involving the
gastrointestinal tract but not limited to it. IBD can be subdivided into Crohn's disease (CD) …

Bone health in inflammatory bowel disease

H Wei, Y Zhao, L Xiang - Expert Review of Gastroenterology & …, 2023 - Taylor & Francis
Introduction Inflammatory bowel disease (IBD) is a chronic disease characterized by the
presence of systemic inflammation, manifesting not only as gastrointestinal symptoms but …

[HTML][HTML] Cardiovascular implications of inflammatory bowel disease: an updated review

A Bhardwaj, A Singh, V Midha, A Sood… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Emerging data highlights the heightened risk of atherosclerotic cardiovascular diseases
(ASCVD) in patients with chronic inflammatory disorders, particularly those afflicted with …

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections

CAM Cavalli, R Gabbiadini, A Dal Buono… - Journal of Clinical …, 2023 - mdpi.com
Inflammatory bowel diseases (IBDs) are chronic, relapsing inflammatory disorders of the
gastrointestinal tract, frequently associated with extraintestinal manifestations (EIMs) that …

Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options

E Diez-Martin, L Hernandez-Suarez… - International Journal of …, 2024 - mdpi.com
In inflammatory bowel diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis
(UC), the immune system relentlessly attacks intestinal cells, causing recurrent tissue …

Personalized therapy in inflammatory bowel disease

P Calderón, P Núñez, P Nos, R Quera - Gastroenterología y Hepatología …, 2024 - Elsevier
Inflammatory bowel diseases (IBD), with ulcerative colitis and Crohn's disease being their
most common presentations, comprise a spectrum of diverse disease phenotypes, exhibiting …

Biologic treatment modification efficacy in concurrent inflammatory bowel disease and ankylosing spondylitis: a retrospective cohort study at a single tertiary center

E Savin, N Ben-Shabat, A Levartovsky, A Lahat… - Journal of Clinical …, 2023 - mdpi.com
Background: The link between ankylosing spondylitis (AS) and inflammatory bowel disease
(IBD) is well-established, with concurrent prevalence estimates ranging from 5–10 …

Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control study

J Sun, J Yao, O Olén, J Halfvarsson… - The Lancet Regional …, 2024 - thelancet.com
Background Co-occurrence of inflammatory bowel disease (IBD) and type 1 diabetes (T1D)
has been linked to poor clinical outcomes, but evidence on their bidirectional associations …

The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and …

FS Macaluso, F Caprioli, L Benedan, C Bezzio… - Autoimmunity …, 2024 - Elsevier
Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with
inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist …